tradingkey.logo
搜索

Cybin Ord Shs

HELP
添加自选
8.870USD
+0.010+0.11%
收盘 11-13 16:00(美东)
705.96M总市值
亏损市盈率 TTM
盘后交易 16:16 (美东)8.810USD-0.040-0.45%

关于 Cybin Ord Shs 公司

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Cybin Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Cybin Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
498.55K
+5.92%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
498.55K
+5.92%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
498.55K
+5.92%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Paul Glavine
Mr. Paul Glavine
Non-Executive Director
Non-Executive Director
4.85M
+32.88%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Chairman Emeritus, Non-Executive Director
Chairman Emeritus, Non-Executive Director
4.77M
+33.35%

常见问题

Cybin Ord Shs的前五大股东是谁?

Cybin Ord Shs 的前五大股东如下:Mr. Paul Glavine

有多少机构持有Cybin Ord Shs(HELP)的股份?

截至2026Q1,共有206家机构持有Cybin Ord Shs的股份,合计持有的股份价值约为31.10M,占公司总股份的60.23%。与2025Q4相比,机构持股有所增加,增幅为-45829674.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有